Does TOCILIZUMAB Cause C-reactive protein abnormal? 3,259 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,259 reports of C-reactive protein abnormal have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 3.3% of all adverse event reports for TOCILIZUMAB.
3,259
Reports of C-reactive protein abnormal with TOCILIZUMAB
3.3%
of all TOCILIZUMAB reports
1,206
Deaths
2,099
Hospitalizations
How Dangerous Is C-reactive protein abnormal From TOCILIZUMAB?
Of the 3,259 reports, 1,206 (37.0%) resulted in death, 2,099 (64.4%) required hospitalization, and 1,321 (40.5%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 3,259 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
TOFACITINIB (2,062)
Which TOCILIZUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE